Oppenheimer Raises PT on Celgene to $84

Symbols: CELG
Share

Oppenheimer has raised the price target on Celgene Corporation (NASDAQ: CELG) from $74 to $84 and maintains its Outperform rating.


 
 
< Previous
UPDATE: Jefferies Raises PT to $23 on Parametric Technology, Reiterates Buy
Next >
Wunderlich Raises PT on F5 Networks to $120
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust